Tuhu Auto Services (Tuhu) has received recognition from multiple authoritative institutions. Behind the many awards is Tuhu's commitment to providing users with high-quality and cost-effective products and high-standard services while ensuring genuine brands.At the annual meeting of the China Automobile Maintenance Industry Association held on December 23, hundreds of Tuhu stores within the Tuhu car maintenance system were awarded the "National Automotive Maintenance Industry Integrity Enterprise" of the year. This recognition is the highest honor for outstanding automotive repair enterprises in the industry and the only recognition activity retained by the Ministry of Transport in the automotive repair industry.Recently, after evaluation and public announcement by the China Automobile Dealers Association, Tuhu has become one of the first batch of "Leaders" in the field of automotive parts circulation. The "Leaders" project for enterprise standards is jointly organized by the State Administration for Market Regulation and other eight departments. It aims to create and cultivate a group of industry-leading enterprises committed to high-quality development and innovation, allowing the industry to have standards, businesses to have benchmarks, and consumers to have perceptions.Junlebao Dairy Group strategically invested in Inatural Biotech, a leading domestic probiotics company, and the two parties will carry out comprehensive cooperation based on strain research and industrial layout.In order to break the long-term foreign monopoly on probiotics and lactic acid bacteria fermentation agents in China and produce more probiotic products with Chinese characteristics, Junlebao strategically invested in Inatural Biotech. As a leading company in the domestic probiotics industry chain, Inatural Biotech has relied on over 10 years of research on Chinese strains to achieve the transformation of technological achievements from strain mechanism research to industrial production. It has formed a complete independent research and development system and has an independent library of functional strains. So far, it has completed industrialized strains for more than 200 strains. Euromonitor data shows that Yiran Biology has been leading in China's bacterial production and sales volume for two consecutive years.Yiran Biology is a leading brand in the Chinese probiotics industry chain, and Junlebao is a leading dairy company in China. This strategic investment by Junlebao is the first dairy company investor introduced by Yiran Biology. Based on long-term cooperation, the two parties have established common goals, which is to continuously strengthen China's domestic competitiveness in probiotics, focus on the research and development of characteristic probiotics, and develop innovative products that meet the health needs of Chinese people, combining probiotics with other elements.On November 1st, Tencent Health and Yuanxin Technology signed a strategic cooperation agreement, and the two parties will promote the comprehensive digitalization upgrade of Yuanxin Technology's various business sectors based on the development and application of medical big models.Tencent will provide comprehensive digitalization capabilities to help Yuanxin Technology innovate its business, upgrade its architecture, and improve its services. This includes enhancing big data analysis capabilities through Tencent Cloud, building an integrated customer service platform for benefiting the people, insurance, and consultation through Tencent Qidian, and creating digital medical services for patient management through Tencent Health's intelligent Q&A capabilities.At the same time, Yuanxin Technology officially launched the "Yuanquan Patient Management Big Model" and "Huibao Big Model". Among them, the "Yuanquan Patient Management Big Model" has gradually covered all Yuanxin Technology pharmacies nationwide and gradually integrated into post-hospital patient health management scenarios. It provides customized disease popularization and medication services for patients through digital applications of big models, focusing on patient medication compliance management, combination drug management, and disease rehabilitation management, providing professional, caring, and comprehensive medical and health services for patients. The "Huibao Big Model" is a dual-integrated big model launched by Yuanxin Technology's Huibao based on the health insurance field. It can be used as an intelligent robot to serve customers, answer inquiries about insurance underwriting, claims, etc., and can also empower insurance salespersons as one of the tools for business development, making them a professional health insurance housekeeper with marketing, claims, and health management knowledge, enhancing service capabilities. The two big model products combine the medical data, drug data, insurance data, and knowledge base accumulated by Tencent Health and Yuanxin Technology for a long time, and are being gradually applied in the medical, pharmaceutical, and insurance fields.In the 4th quarter of 2023, the portfolio invested by Starquest Capital's GP in Technological Enterprise Services is in process of IPO.Source Code Capital’s portfolio company, J&T Express (01519.HK), an internet express logistics company, was listed on Hong Kong Stock Exchange on October 27, 2023 at an offering price of HKD 12.00 per share, raising a total of HKD 3.528 billion. The company’s market capitalization exceeded more than HKD 100 billion on the first day of listing.Over the past three months, a number of portfolio companies of Starquest GPs' have completed the next round of financing in Technological Enterprise Services and Healthcare.Technological Enterprise ServicesAI-driven intelligent legal service provider, Power Law Intelligence, the portfolio company of Source Code Capital and Linear Capital, completed nearly 80 million RMB in a Series Pre-B round of financing. This round of financing was led by Lanchi Ventures, with participation from eSignChina. Existing shareholders such as Sequoia Capital, Huayu Capital, Source Code Capital, Linear Capital, and ZHIPU AI continued to invest.Both Source Code Capital and GGV Capital’s portfolio company, RaySolve, a Micro-LED micro-display chip developer, completed a Series Pre-A3 strategic round of financing. This round of financing was led by Meridian Capital, with participation from 37 Interactive Entertainment and miHoYo.GravityXR, an XR chip developer invested by GGV Capital, completed hundreds of millions of RMB in a Series A round of financing. This round of financing was led by Monolith Management, with participation from Ningbo Tongshang Fund, CICC Capital, and Haiding Capital. Existing shareholders miHoYo, Glory Ventures, Resonance Ventures, Zhongyuan Capital, 37 Interactive Entertainment, and Sequoia Capital continued to invest.DSTCar, invested by IDG Capital, a global leader in new energy logistics vehicles, completed nearly 600 million RMB in a Series E round of financing. This round of financing was led by a globally renowned growth fund.ZhenFund’s portfolio company, Salus BioMed, a genetic sequencing technology and equipment developer, completed hundreds of millions of RMB in a Series A round of financing. This round of financing was led by SCGC, with joint leadership from Qianhai FOF and BioTrack Capital. Investors such as Bioching Capital, Honest Capital, and Yazhouwan Capital also participated. Cispoly, a gynecologic tumor early screening service provider invested by ZhenFund, completed over 100 million RMB in a Series B round of financing. This round of financing was led by Prosperity7 Ventures, a diversified growth fund under AramcoVentures. Existing shareholder Sunland Capital also increased its investment.Gaorong Capital’s portfolio company, WeLinking, a wireless brain-computer interface system developer, completed tens of millions of RMB in a Series Angel+ round of financing. This round of financing was led by Gaorong Capital, with participation from Zhongfa Lingchuang Life Park Investment Fund and TTM Capital. Existing shareholder CDH Investment also made follow-on investments.In the past three months, Starquest Capital received multiple industry honorsOn December 7, 2023, FOFWEEKLY released its 2023 Investment Industry Young Leaders list, and Mr. Frankie Fang, founding managing partner of Starquest Capital, was honored as one of the "Top10 Investment Industry Annual Figures - Socially Responsible Investors in 2023".
On December 11, 2023, FOF Research Center officially released its annual list. Starquest Capital was included in the list and honored as one of the "Top 20 Best Market-oriented FOFs in 2023". Additionally, in the list of individuals, Mr. Frankie Fang was named one of the "Top 50 Best FOF Investors in 2023".On November 13, 2023, Mr. Frankie Fang, Managing Partner of Starquest Capital, was invited to attend the 2023 AVCJ Private Equity & Venture Capital Forum. He shared his views on the topic "What to expect in 2024: Creating Value by Integrating ESG".
5月 19 · 已讀1分鐘
